Do "screening" coagulation tests predict bleeding in patients undergoing fiberoptic bronchoscopy with biopsy?

To determine if preprocedure coagulation testing predicts bleeding in patients undergoing flexible fiberoptic bronchoscopy (FOB) with biopsy. Retrospective chart review. Southeastern, urban Veteran Affairs Medical Center. Two hundred seventy-four patient charts representing 305 FOB with biopsy were...

Full description

Saved in:
Bibliographic Details
Published inChest Vol. 106; no. 3; p. 703
Main Authors Kozak, E A, Brath, L K
Format Journal Article
LanguageEnglish
Published United States 01.09.1994
Subjects
Biopsy - adverse effects
Biopsy - statistics & numerical data
Blood Coagulation Tests
Bronchi - pathology
Bronchial Diseases - epidemiology
Bronchial Diseases - etiology
Bronchoscopy - adverse effects
Bronchoscopy - statistics & numerical data
Chi-Square Distribution
Fiber Optic Technology
Hemorrhage - epidemiology
Hemorrhage - etiology
Humans
Partial Thromboplastin Time
Preoperative Care - statistics & numerical data
Prevalence
Prognosis
Prothrombin Time
Retrospective Studies
Risk Factors
Virginia - epidemiology
Virginia
Online AccessGet more information

Cover

More Information
Summary:To determine if preprocedure coagulation testing predicts bleeding in patients undergoing flexible fiberoptic bronchoscopy (FOB) with biopsy. Retrospective chart review. Southeastern, urban Veteran Affairs Medical Center. Two hundred seventy-four patient charts representing 305 FOB with biopsy were reviewed for clinical predictors of bleeding, prebronchoscopy laboratory abnormalities, and incidence of bleeding complications. Thirty-five patients bled, and 3 had abnormal results of coagulation studies. Normal results of coagulation studies and no clinical risk factors were noted in 68 percent of patients who bled. Patients undergoing flexible FOB with biopsy do not benefit from preprocedure coagulation testing.
ISSN:0012-3692
DOI:10.1378/chest.106.3.703